Amnon Schlegel, MD, PhD

Languages Spoken: English

Labs: Website

Dr. Schlegel sees patients with lipid disorders and type 2 diabetes mellitus requiring complex medical therapy at the Utah Diabetes and Endocrinology Center. He sees patients with all endocrine and metabolic disorders at the Endocrinology clinic at the George E. Wahlen Department of Veterans Affairs Medical Center. Dr. Schlegel also performs one month annually of in-patient Endocrinology consultations at the University of Utah Medical Center (including Huntsman Cancer Hospital and Neuropsychiatric Institute).

Dr. Schlegel was a trainee in the Medical Scientist Training Program of the Albert Einstein College of Medicine where he received his M.D. and Ph.D. He was an intern and resident physician at Beth Israel Deaconess Medical Center in Boston, MA, and was a Fellow in Medicine at Harvard Medical School. He was a clinical fellow in the Diabetes, Endocrine, and Metabolism Training Program at the University of California San Francisco, where he was subsequently a post-doctoral associate in the laboratory of Professor Didier Y.R. Stainier, Ph.D., in the Department of Biochemistry and Biophysics. It was there that he established a zebrafish molecular genetic system for studying lipid metabolism.

In 2010, Dr. Schlegel was recruited to the University of Utah as an investigator in the Molecular Medicine Program and as an Assistant Professor of Internal Medicine and Biochemistry. He was promoted to Associate Professor with award of tenure in 2016. He hosts graduate students in his lab through the Molecular Biology and Biological Chemistry Graduate programs. His laboratory uses model organisms (zebrafish and mice) to identify and characterize new genes that participate in lipid metabolism. The long-term goal of this work is to identify novel therapeutic targets for treating obesity, type 2 diabetes, and lipid disorders.